CPAP and oxygen therapy prior authorization: avoiding the 30% denial rate.
CPAP and home oxygen are two of the most common items pulmonology bills and two of the most heavily gated. Both HCPCS E0601 (CPAP) and E1390 (oxygen concentrator) sit on CMS's Required Prior Authorization list for DMEPOS, both are governed by DME MAC local coverage policy with specific numeric thresholds, and both carry a second authorization checkpoint after the initial approval that a surprising number of practices never build into their workflow. This guide goes past "get a prior auth" into the actual AHI/RDI and blood-gas numbers, the document IDs behind them, and the two-part re-evaluation that decides whether coverage continues past the first 90 days.
Key takeaways
- E0601 (CPAP) and E1390 (oxygen concentrator) are both on CMS's DMEPOS Required Prior Authorization Master List. Medical necessity alone doesn't move the claim — an approved PA number has to exist before the equipment goes out the door.
- The AHI/RDI threshold decides how much documentation the chart needs. 15+ events per hour needs nothing beyond the study itself; 5–14 needs a specific symptom or comorbidity spelled out in the note (LCD L33718).
- Oxygen coverage runs on two blood-gas tiers, not one. Group I and Group II under LCD L33797 take different modifiers (N1 vs. N2), and Group II always needs a second qualifying factor on top of the number itself.
- Continued CPAP coverage past 90 days needs a visit note and a compliance download together, in the same encounter. Submitting either one alone is one of the specialty's most avoidable denials.
Why this pair of items denies harder than almost anything else in pulmonology
CPAP and oxygen aren't denied because the equipment is clinically wrong for the patient — they're denied because the claim has to clear three separate gates and most workflows are only built to clear one. The first gate is a DME MAC local coverage determination with a specific numeric threshold: an AHI/RDI cutoff for CPAP, a blood-gas cutoff for oxygen. The second gate is prior authorization itself, which for both items is a condition of payment under CMS's DMEPOS Required Prior Authorization program, not a courtesy check. The third gate is a re-evaluation checkpoint after the initial approval, which most practices treat as a formality and most payers treat as a hard requirement. Miss any one of the three and the claim denies regardless of how appropriate the therapy is.
CPAP prior authorization: the AHI/RDI gate
CPAP (HCPCS E0601) is governed by LCD L33718, Positive Airway Pressure (PAP) Devices for the Treatment of Obstructive Sleep Apnea, jointly published by DME MACs CGS Administrators and Noridian Healthcare Solutions, effective 01/01/2024, with its companion Policy Article A52467 last updated 05/08/2024. The medical necessity threshold is a specific numeric split, not a single cutoff:
| AHI/RDI result | What the chart needs |
|---|---|
| ≥15 events/hour (minimum 30 events on the study) | Qualifies on the study alone — no additional symptom documentation required |
| 5–14 events/hour (minimum 10 events on the study) | Qualifies only with documented excessive daytime sleepiness, impaired cognition, a mood disorder, or insomnia — or a history of hypertension, ischemic heart disease, or stroke |
| <5 events/hour | Does not meet CPAP medical necessity under this LCD |
The 5–14 tier is where most preventable CPAP denials start. A sleep study result alone is enough to order the device clinically, but it is not enough to satisfy the LCD unless the qualifying symptom or comorbidity is written into the same chart — not implied by the diagnosis, stated. A note that says "OSA, AHI 9" without naming daytime sleepiness, a mood disorder, or one of the listed comorbidities reads as unqualified on review even when the patient's condition is real.
E0601 sits on CMS's DMEPOS Required Prior Authorization Master List, which means an approved prior authorization number is a condition of payment, not just good practice. CMS's January 13, 2026 Federal Register update to the master list took effect April 13, 2026 and added several oxygen-related codes to the parallel face-to-face/written-order-prior-to-delivery requirement — confirm your supplier's current list placement before assuming an item's PA status hasn't changed year over year, since these lists are revised on their own schedule.
When a bi-level RAD device replaces CPAP — and needs its own authorization
Respiratory assist devices (bi-level PAP, HCPCS E0470/E0471 depending on backup-rate capability) are governed by a separate policy: LCD L33800, Respiratory Assist Devices, from the same two DME MACs, effective 06/09/2025. RAD coverage applies to patients who fail CPAP therapy, who have OSA with a hypoventilation component, or who have a separate qualifying diagnosis such as severe COPD with hypercapnia or a restrictive thoracic disorder — it is not simply "CPAP didn't work, try the next device."
Because L33718 and L33800 are two separate LCDs, an existing CPAP prior authorization does not carry over to a RAD device. Treat the switch as a new order from scratch: new qualifying documentation against L33800's criteria, a new Standard Written Order naming the RAD device specifically, and a new PA submission — not an amendment request against the old CPAP authorization number.
Oxygen therapy: Group I vs. Group II and the modifier that proves it
Home oxygen equipment is governed by LCD L33797, Oxygen and Oxygen Equipment, from CGS and Noridian, effective 04/01/2023, with companion Policy Article A52514 last updated 05/09/2024. Coverage runs on a blood-gas result placed into one of two tiers, and the tier a patient falls into determines both what else has to be in the chart and which modifier goes on the claim.
| Group | Qualifying result | Additional requirement | Claim modifier |
|---|---|---|---|
| Group I | Arterial PaO2 ≤55 mmHg, or O2 saturation ≤88% | None — the result alone qualifies | N1 |
| Group II | PaO2 56–59 mmHg, or O2 saturation of 89% | Plus one of: dependent edema suggesting heart failure, P pulmonale on EKG, hematocrit ≥56%, or documented cor pulmonale/pulmonary hypertension | N2 |
The qualifying test itself has to be done at the testing condition the equipment is ordered for — rest, exercise, or sleep — and a result drawn during exertion doesn't automatically support a rest-only order or vice versa. A face-to-face visit with the treating practitioner within the 30 days prior to the initial certification is required, along with documentation that alternative, non-oxygen treatment measures were tried or specifically considered and found clinically insufficient. Applying the N1 modifier to a Group II result, or omitting the second qualifying factor a Group II claim needs beyond the blood-gas number, are both common, avoidable coding-level denials rather than genuine coverage disputes.
Equipment HCPCS follows the delivery method actually ordered, and stationary and portable components are billed as distinct codes rather than one system:
| Code | Equipment |
|---|---|
E1390/E1391 | Stationary oxygen concentrator, single/dual delivery port |
E0424 | Stationary compressed gas system, rental |
E0439 | Stationary liquid oxygen system, rental |
E0431 | Portable gaseous oxygen system, rental |
E0434 | Portable liquid oxygen system, rental |
E1392 | Portable oxygen concentrator, rental |
Group II coverage carries its own continuation checkpoint, separate from CPAP's: a beneficiary who initially qualified under Group II needs to be re-evaluated and retested between the 61st and 90th day of therapy for coverage to continue past that window. Group I doesn't carry the same automatic retest requirement. Treating Group I and Group II as interchangeable for follow-up scheduling purposes is how a Group II patient's oxygen quietly lapses at day 91.
The CPAP re-evaluation: one requirement, two parts
Continued CPAP coverage past the initial trial hinges on a single encounter between the 31st and 91st day of therapy that has to do two things at once: the treating practitioner documents that the patient's OSA symptoms have improved, and that same visit reviews the objective adherence data pulled from the device — use on at least 70% of nights, at least 4 hours per night, across a consecutive 30-day period within the first 90 days. Both elements need to trace to the same encounter. A compliance report faxed over on its own, with no accompanying visit note describing symptomatic improvement, satisfies the data half of the requirement and leaves the clinical half unaddressed — and payers that scrutinize CPAP continuation claims are checking for both.
Accessory resupply: the quiet volume denial
Mask and tubing resupply generates far more line-item denials than the initial device authorization, because it's high-volume, low-dollar-per-claim, and easy to automate past the point of compliance. DME MAC guidance publishes maximum replacement frequencies per accessory — these are ceilings tied to actual patient need and contact, not an entitlement to auto-ship on a calendar:
| Code | Accessory | Typical maximum frequency |
|---|---|---|
A7030/A7034 | Full face mask / nasal mask | 1 per 3 months |
A7031/A7032 | Mask cushion/interface (full face / nasal) | 1–2 per month |
A7035 | Headgear | 1 per 6 months |
A7038/A7039 | Disposable / non-disposable filter | 2 per month / 1 per 6 months |
A resupply denial almost never means the patient stopped needing the item — it means the claim shipped ahead of the documented need date, or without the patient contact that CMS requires suppliers to log before each resupply shipment. Build the contact log into the resupply workflow itself; reconstructing it after a post-payment audit request rarely produces a usable record.
Do and don't
- Name the specific symptom or comorbidity in the note whenever a CPAP AHI/RDI result falls in the 5–14 range.
- Confirm PA is submitted and approved for E0601 and E1390 before equipment ships — both are on the federal Required PA Master List.
- Schedule the day-31-to-91 CPAP visit to capture symptom improvement and the compliance download in one encounter.
- Flag Group II oxygen patients for the day-61-to-90 retest separately from the CPAP compliance calendar — they're different clocks.
- Don't assume a CPAP prior authorization carries over when a patient is switched to a RAD device — L33718 and L33800 are separate policies.
- Don't submit a compliance download alone as the day-31-to-91 re-evaluation — it needs a visit note documenting symptom improvement alongside it.
- Don't apply modifier N1 to a Group II oxygen result, or bill Group II without the second qualifying factor.
- Don't auto-ship accessory resupply on a calendar without a logged patient contact confirming continued need.
Losing CPAP and oxygen claims to prior authorization?
We'll audit a sample of your recent DME prior-auth submissions, name the specific LCD threshold or re-evaluation gap behind the denials, and show what's recoverable.
Frequently asked questions
What AHI or RDI qualifies a patient for CPAP coverage under Medicare?
An AHI or RDI of 15 or more events per hour, with a minimum of 30 events on the study, qualifies on its own under LCD L33718. Between 5 and 14 events per hour, with a minimum of 10 events, only qualifies when the chart also documents excessive daytime sleepiness, impaired cognition, a mood disorder, or insomnia, or a history of hypertension, ischemic heart disease, or stroke. A study showing an AHI of 8 with no symptom or comorbidity documentation doesn't meet the coverage bar even though it shows real disease.
Do we need a new prior authorization when a patient switches from CPAP to a bi-level RAD device?
Yes. CPAP and RAD devices sit under two separate LCDs (L33718 for CPAP, L33800 for respiratory assist devices), each with its own medical necessity criteria and its own authorization. A patient failing CPAP doesn't automatically qualify for a RAD device on the strength of the original CPAP order; the switch needs its own qualifying documentation, a new order specific to the RAD device, and its own prior authorization submission, not an amendment to the existing CPAP authorization.
How is the day-31-to-91 CPAP re-evaluation different from the compliance download?
They're two components of one requirement, not two separate ones. Medicare requires a face-to-face clinical re-evaluation between the 31st and 91st day of therapy where the treating practitioner documents improvement in OSA symptoms, and that same visit has to review the objective adherence data pulled from the device (70% of nights, 4+ hours, across a consecutive 30-day period). Submitting the compliance report alone without a visit note describing symptomatic improvement satisfies only half of what continued coverage requires.
Verify before billing. CPT is a registered trademark of the American Medical Association; codes here are paraphrased, not reproduced from the CPT Professional edition. CPT, HCPCS and ICD-10 codes, coverage policy, and bundling edits change, including annual code-set updates. This page reflects standard industry practice and is provided for general education — it is not a substitute for your own compliance review, your current payer contracts, or the current-year code sets. Confirm requirements against your specific payer mix before submitting claims.